Bottom line: Evidence generally supports giving an initial crystalloid bolus to SIRS-positive or early sepsis patients—even with pre-existing congestive heart failure (CHF)—but the strength of evidence is low, and many studies are observational. After the initial bolus, ongoing fluids should be individualized using dynamic assessments (e.g., PLR, ultrasound) and early vasopressors if hypotension persists (1–5, 8–10).
Why fluids at all?
Sepsis and septic shock cause relative and absolute intravascular depletion from vasodilation, capillary leak, and insensible losses; initial crystalloid resuscitation improves perfusion while antibiotics and source control take effect. Contemporary randomized trials in sepsis (not CHF-specific) comparing restrictive vs liberal strategies (after an initial liter or so) show no mortality difference overall, reinforcing that early fluids are appropriate but that “more” is not always better (6, 7).
What do guidelines say about patients with CHF?
The Surviving Sepsis Campaign (SSC) 2021 suggests at least 30 mL/kg IV crystalloid within 3 hours for sepsis-induced hypoperfusion or septic shock; this is a weak recommendation with low-quality evidence and does not exclude CHF. U.S. guidelines echo this: give the initial bolus, then switch to dynamic, perfusion-guided reassessment (1, 2).
What actually happens in practice with CHF?
CHF patients frequently receive less than 30 mL/kg because of overload concerns. In a multicenter cohort of 5,278 patients with community-onset sepsis, preexisting HFrEF was associated with lower odds of receiving 30 mL/kg in 6 hours, without higher mortality compared to non-HFrEF (3).
Does the initial bolus help—or harm—when CHF is present
Observational evidence (ED/early care)
A retrospective case-control study found that ≥30 mL/kg within 6 hours in severe sepsis/septic shock decreased in-hospital mortality in CHF patients and did not increase mechanical ventilation (4).
A systematic review and meta-analysis comparing guideline-based (≥30 mL/kg) vs restrictive (<30 mL/kg) strategies in septic patients with HF suggested lower mortality with guideline-based fluids, though data quality was limited and heterogeneous (5).
Patients with acutely decompensated HF (ADHF)
In septic patients with ADHF, observational data suggest a U-shaped relationship with outcomes. Optimal early fluid volume appeared to be 10–15 mL/kg in the first 3 hours; volumes >15 mL/kg increased intubation risk (8).
ICU course beyond the first hours
Positive cumulative fluid balance over the first ICU days correlates with worse outcomes; thus, even if you give an initial bolus, aim to avoid persistent positive balance thereafter (9).
How do sepsis trials inform CHF care?
CLOVERS (2023): In sepsis-induced hypotension, a restrictive strategy with earlier vasopressors vs a liberal-fluid strategy resulted in no difference in 90-day mortality; subgroup analyses including CHF did not show a differential effect (6).
CLASSIC (2022): In ICU septic shock after initial resuscitation, restrictive vs standard fluids showed no mortality difference, supporting careful titration rather than automatic large volumes (7).
Practical, evidence-based approach for SIRS-positive patients at risk for sepsis with CHF
Give an initial crystalloid bolus if hypotension or hypoperfusion is present. For stable, borderline patients or known ADHF, consider 10–15 mL/kg as a starting target and reassess closely (1, 2, 8).
Reassess dynamically after each small bolus (e.g., passive leg raise, ultrasound indices, skin perfusion, urine output, lactate trend). If non-responsive or fluid-intolerant, stop fluids (1, 2).
Start vasopressors early if MAP remains low after limited fluids; this may limit fluid burden (6, 7).
Avoid cumulative overload: prioritize de-resuscitation once shock resolves, track daily balance, and target euvolemia (9).
Document rationale when deviating from 30 mL/kg (e.g., pulmonary edema, high filling pressures, RV failure), as compliance metrics may still reference guideline targets despite weak evidence (1, 3, 10).
Conclusion
For SIRS-positive patients at risk for sepsis with CHF, the literature supports an initial crystalloid bolus, but not indiscriminate large volumes. Observational data (including CHF-specific cohorts) show no clear harm and possible benefit to achieving guideline-level early fluids, while newer data in ADHF argue for smaller initial volumes (≈10–15 mL/kg) with rapid reassessment. After the first bolus, tailor therapy with dynamic tests and consider early vasopressors to avoid fluid overload (1–8).
References
(1) Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: 2021 International Guidelines. Intensive Care Med. 2021;47:1181–1247.
(2) American Academy of Family Physicians. Practice Guidelines: Sepsis. Am Fam Physician. 2022;106(5):576–584.
(3) Powell RE, Kennedy JN, Senussi MH, et al. Association Between Preexisting HFrEF and Fluid Administration Among Patients With Sepsis. JAMA Netw Open. 2022;5(10):e2235331.
(4) Acharya R, Patel A, Schultz E, et al. Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: a retrospective case-control study. PLoS One. 2021;16(8):e0256368.
(5) Vaeli Zadeh A, Wong A, Crawford AC, et al. Guideline-based vs restricted fluid resuscitation in sepsis patients with heart failure: a systematic review & meta-analysis. Am J Emerg Med. 2023;73:
(6) The CLOVERS Trial Investigators. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl J Med. 2023;388:499–510.
(7) Meyhoff TS, et al. CLASSIC Trial: Restrictive vs Standard IV fluids in septic shock. N Engl J Med. 2022;386:2459–2470.
(8) Zhang Z, et al. Optimal fluid resuscitation in septic patients with acutely decompensated heart failure (ADHF). BMC Medicine. 2024;22:—.
(9) Sutherland A, et al. Fluid boluses/infusions in early septic shock and associations with positive balance. Annals of Intensive Care. 2024;14:—.
(10) Singer AJ, et al. Emergency Medicine Updates: Management of Sepsis and Septic Shock. Am J Emerg Med. 2025;—.
